SPY749.60−0.63%QQQ674.25−0.83%BTC/USD66,888.80−1.97%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

Premium Services

Eikon Therapeutics Inc

EIKNNASDAQ

Trade with Public

Trade with Public

$5.98

-0.06-0.99%

Last update: Nov 13, 4:26 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contribute
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Eikon Therapeutics (EIKN) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Eikon Therapeutics (EIKN) stock.

Analyst Consensus — 7 Analysts

6Buy

1Sell

# Analysts7

Latest Upgrades and Downgrades for Eikon Therapeutics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Sara Nik	Initiate	Buy	$23
—	Wedbush	Robert Driscoll	PT Cut	Underperform	$5→$4
—	Wedbush	Robert Driscoll	PT Cut	Underperform	$7→$5
—	Wedbush	Robert Driscoll	Maintained	Underperform	$7
—	Cantor Fitzgerald	Imogen Mansfield	Initiate	Overweight	—
—	JP Morgan	Brian Cheng	Initiate	Overweight	$29
—	B of A Securities	Jason Zemansky	Initiate	Buy	$34
—	Mizuho	Joseph Catanzaro	Initiate	Outperform	$26
—	Morgan Stanley	Sean Laaman	Initiate	Overweight	$32
—	Wedbush	Robert Driscoll	Initiate	Underperform	$7